Natural Abundance 13C in Liver

Methods for quantifying hepatic glycogen at 3T.

Clinical Relevance

Natural abundance Carbon-13 MRS is the gold standard for non-invasive measurement of hepatic glycogen concentrations in humans. Unlike biopsy, it assesses a larger volume of tissue and can be repeated frequently to monitor metabolic changes (e.g., post-prandial glycogen storage, effects of insulin, or exercise).

Technical Challenges at 3T

Sensitivity Issues

13C has a natural abundance of only 1.1% and a gyromagnetic ratio one-quarter that of protons. This results in very low signal-to-noise ratio (SNR), necessitating:

  • Surface Coils: Essential for maximizing sensitivity near the liver surface.
  • Proton Decoupling: Required to collapse multiplet splitting and enhance signal via the Nuclear Overhauser Effect (NOE).
  • Long Scan Times: Often 15-30 minutes of signal averaging is required for sufficient SNR.

SAR Limitations

Broadband proton decoupling deposits significant RF energy into the patient. At 3T, keeping within Specific Absorption Rate (SAR) limits is the primary constraint. Power-optimized decoupling schemes (e.g., WALTZ-4, WALTZ-16, or adiabatic pulses) and duty cycling are critical.

Spectral Features

[Spectra Graphic: Glycogen C1 Peak at ~100.5 ppm]

The primary target is the Glycogen C1 resonance at approximately 100.5 ppm.

Acquisition Protocol (Typical)